2-Bromo-5-(trifluoromethyl)pyridine → N-(4-Methoxybenzyl)-N,7-dimethyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazin-4-amine

HRID 1907205

Reaktionsgleichung

Reaktionsgleichung von HRID 1907205
Br[C:2]1[N:6]([CH3:7])[N:5]=[CH:4][C:3]=1[C:8]1[N:9]=[C:10]([CH3:28])[N:11]2[C:16]=1[C:15]([N:17]([CH2:19][C:20]1[CH:25]=[CH:24][C:23]([O:26][CH3:27])=[CH:22][CH:21]=1)[CH3:18])=[N:14][CH:13]=[N:12]2.C([Li])CCCCC.Br[C:37]1[CH:42]=[CH:41][C:40]([C:43]([F:46])([F:45])[F:44])=[CH:39][N:38]=1>O1CCCC1.[Cl-].[Zn+2].[Cl-].C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH3:27][O:26][C:23]1[CH:24]=[CH:25][C:20]([CH2:19][N:17]([CH3:18])[C:15]2[C:16]3=[C:8]([C:3]4[CH:4]=[N:5][N:6]([CH3:7])[C:2]=4[C:37]4[CH:42]=[CH:41][C:40]([C:43]([F:46])([F:45])[F:44])=[CH:39][N:38]=4)[N:9]=[C:10]([CH3:28])[N:11]3[N:12]=[CH:13][N:14]=2)=[CH:21][CH:22]=1

Komponenten

7

Versuchsvorschrift

A solution of 5-(5-bromo-1-methyl-1H-pyrazol-4-yl)-N-(4-methoxybenzyl)-N,7-dimethylimidazo[5,1-f][1,2,4]triazin-4-amine (3.35 g, 7.57 mmol) in tetrahydrofuran (75 mL) was cooled to −78° C. and treated over 5 minutes with n-hexyllithium (2.3 M solution in hexane, 3.46 mL, 7.96 mmol). The reaction mixture was stirred for 30 minutes, and then treated in one portion with a −78° C. solution of zinc chloride (99.5%, 1.30 g, 9.49 mmol) in tetrahydrofuran (20 mL). After stirring for 5 minutes at −78° C., the reaction was warmed to room temperature over 30 minutes. After addition of 2-bromo-5-(trifluoromethyl)pyridine (2.57 g, 11.4 mmol), the reaction mixture was heated to 50° C., treated with tetrakis(triphenylphosphine)palladium(0) (99.9%, 87.9 mg, 0.076 mmol), and maintained at reflux for 4 hours. The reaction was cooled and concentrated in vacuo; the residue was dissolved in ethyl acetate and washed sequentially with water, saturated aqueous ammonium chloride solution, and saturated aqueous sodium bicarbonate solution. After drying over magnesium sulfate, the product solution was filtered and concentrated in vacuo. Purification via silica gel chromatography (Gradient: 0% to 100% ethyl acetate in heptane) provided a pale yellow oil (2.3 g), which was crystallized from heptane to afford the product as a white powder. Yield: 1.58 g, 3.11 mmol, 41%. APCI m/z 509.5 (M+1). 1H NMR (400 MHz, CDCl3) δ 2.54 (s, 3H), 2.72 (s, 3H), 3.76 (s, 3H), 4.14 (s, 3H), 4.34 (br s, 2H), 6.76 (br d, J=8.8 Hz, 2H), 6.94 (br d, J=8.5 Hz, 2H), 7.39 (d, J=8.3 Hz, 1H), 7.72 (s, 1H), 7.76 (dd, J=8.4, 2.2 Hz, 1H), 7.85 (s, 1H), 8.94-8.96 (m, 1H).

Aufarbeitung

  1. stirringAfter stirring for 5 minutes at −78° C.
  2. temperaturethe reaction mixture was heated to 50° C.
  3. temperaturemaintained
  4. temperatureat reflux for 4 hours
  5. temperatureThe reaction was cooled
  6. concentrationconcentrated in vacuo
  7. dissolutionthe residue was dissolved in ethyl acetate
  8. washwashed sequentially with water, saturated aqueous ammonium chloride solution, and saturated aqueous sodium bicarbonate solution
  9. dry with materialAfter drying over magnesium sulfate
  10. filtrationthe product solution was filtered
  11. concentrationconcentrated in vacuo
  12. customPurification via silica gel chromatography (Gradient: 0% to 100% ethyl acetate in heptane)

Quellen und Nachweise

ORD-Eintrag
ord-179d2b97de3240ec868129a76326e8e5
Quelldatensatz
uspto-grants-2013_12
Patentnummer
US08598155B2

Verknüpfte Notizen

Wird geladen…